BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30220049)

  • 1. Receptor pharmacophore ensemble (REPHARMBLE): a probabilistic pharmacophore modeling approach using multiple protein-ligand complexes.
    Kumar SP
    J Mol Model; 2018 Sep; 24(10):282. PubMed ID: 30220049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of the Butina algorithm and ensemble learning strategies for the advancement of a pharmacophore ligand-based model: an
    Tran XD; Phan TL; To VT; Tran NN; Nguyen NS; Nguyen DH; Tran NN; Truong TN
    Front Chem; 2024; 12():1382319. PubMed ID: 38690013
    [No Abstract]   [Full Text] [Related]  

  • 3. BgN-Score and BsN-Score: bagging and boosting based ensemble neural networks scoring functions for accurate binding affinity prediction of protein-ligand complexes.
    Ashtawy HM; Mahapatra NR
    BMC Bioinformatics; 2015; 16 Suppl 4(Suppl 4):S8. PubMed ID: 25734685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PharmRF: A machine-learning scoring function to identify the best protein-ligand complexes for structure-based pharmacophore screening with high enrichments.
    Kumar SP; Dixit NY; Patel CN; Rawal RM; Pandya HA
    J Comput Chem; 2022 May; 43(12):847-863. PubMed ID: 35301752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-level structure-based pharmacophore modelling of caspase-3-non-peptide complexes: Extracting essential pharmacophore features and its application to virtual screening.
    Kumar SP; Jha PC
    Chem Biol Interact; 2016 Jul; 254():207-20. PubMed ID: 27291469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Machine learning in computational docking.
    Khamis MA; Gomaa W; Ahmed WF
    Artif Intell Med; 2015 Mar; 63(3):135-52. PubMed ID: 25724101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Molecular Dynamics-Shared Pharmacophore Approach to Boost Early-Enrichment Virtual Screening: A Case Study on Peroxisome Proliferator-Activated Receptor α.
    Perricone U; Wieder M; Seidel T; Langer T; Padova A; Almerico AM; Tutone M
    ChemMedChem; 2017 Aug; 12(16):1399-1407. PubMed ID: 28135036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ProPose: steered virtual screening by simultaneous protein-ligand docking and ligand-ligand alignment.
    Seifert MH
    J Chem Inf Model; 2005; 45(2):449-60. PubMed ID: 15807511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ligand and structure-based approaches for the identification of SIRT1 activators.
    Vyas VK; Goel A; Ghate M; Patel P
    Chem Biol Interact; 2015 Feb; 228():9-17. PubMed ID: 25595223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common Hits Approach: Combining Pharmacophore Modeling and Molecular Dynamics Simulations.
    Wieder M; Garon A; Perricone U; Boresch S; Seidel T; Almerico AM; Langer T
    J Chem Inf Model; 2017 Feb; 57(2):365-385. PubMed ID: 28072524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probabilistic Approach for Virtual Screening Based on Multiple Pharmacophores.
    Madzhidov TI; Rakhimbekova A; Kutlushuna A; Polishchuk P
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31963467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel approach for efficient pharmacophore-based virtual screening: method and applications.
    Dror O; Schneidman-Duhovny D; Inbar Y; Nussinov R; Wolfson HJ
    J Chem Inf Model; 2009 Oct; 49(10):2333-43. PubMed ID: 19803502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pseudo-ligand approach to virtual screening.
    Schüller A; Fechner U; Renner S; Franke L; Weber L; Schneider G
    Comb Chem High Throughput Screen; 2006 Jun; 9(5):359-64. PubMed ID: 16787149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the stability of pharmacophore features using molecular dynamics simulations.
    Wieder M; Perricone U; Boresch S; Seidel T; Langer T
    Biochem Biophys Res Commun; 2016 Feb; 470(3):685-689. PubMed ID: 26785387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein flexibility in ligand docking and virtual screening to protein kinases.
    Cavasotto CN; Abagyan RA
    J Mol Biol; 2004 Mar; 337(1):209-25. PubMed ID: 15001363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of pharmacophore screening tools.
    Sanders MP; Barbosa AJ; Zarzycka B; Nicolaes GA; Klomp JP; de Vlieg J; Del Rio A
    J Chem Inf Model; 2012 Jun; 52(6):1607-20. PubMed ID: 22646988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophore Models Derived From Molecular Dynamics Simulations of Protein-Ligand Complexes: A Case Study.
    Wieder M; Perricone U; Seidel T; Langer T
    Nat Prod Commun; 2016 Oct; 11(10):1499-1504. PubMed ID: 30549607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling.
    Yu W; Lakkaraju SK; Raman EP; MacKerell AD
    J Comput Aided Mol Des; 2014 May; 28(5):491-507. PubMed ID: 24610239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beware of machine learning-based scoring functions-on the danger of developing black boxes.
    Gabel J; Desaphy J; Rognan D
    J Chem Inf Model; 2014 Oct; 54(10):2807-15. PubMed ID: 25207678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational screening, ensemble docking and pharmacophore analysis of potential gefitinib analogues against epidermal growth factor receptor.
    Bommu UD; Konidala KK; Pamanji R; Yeguvapalli S
    J Recept Signal Transduct Res; 2018 Feb; 38(1):48-60. PubMed ID: 29369008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.